More on EWTX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-38.2% Growth)
- Ratings (7.9 Score)

Upcoming Events

- Earnings (8/6/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Edgewise Therapeutics Inc. (NQ:EWTX)
Delayed: 40.84 --0 (-0%)
Prev. Close $40.84  
Open$40.84 
52 Wk High$ 
52 Wk Low$ 
Day High$40.84 
Day Low$40.84 
P/E N/A  
EPS$ 
Volume40 

Friends, Peers and Foes (?): ACAD, BCRX, CATX, CDTX, CRBP (more...)

Jul 17, 2026 04:25 PM Form 4 Edgewise Therapeutics, For: Jun 05 Filed by: ROOT JONATHAN D
Jul 16, 2026 08:01 AM Form 8-K/A Edgewise Therapeutics, For: Jul 10
Jul 13, 2026 08:37 AM Form 8-K Edgewise Therapeutics, For: Jul 10
Jul 13, 2026 08:30 AM Edgewise sells muscular dystrophy drug to Servier for up to $2.65B
Jul 13, 2026 08:30 AM Servier buys Edgewise muscular dystrophy unit for up to $2.65B
Jul 13, 2026 08:30 AM Edgewise Therapeutics Completes Sale of Sevasemten for Up to $2.65 Billion, Strengthening Balance Sheet and Centering Company Focus on Cardiovascular Pipeline
Jul 13, 2026 08:30 AM Servier completes the acquisition of Edgewise Therapeutics' Muscular Dystrophy Business
Jul 9, 2026 06:01 AM Oppenheimer Starts Edgewise Therapeutics (EWTX) at Outperform
Jul 6, 2026 08:17 AM Edgewise Therapeutics (EWTX) PT Raised to $51 at Guggenheim
Jul 2, 2026 05:21 PM Form 4 Edgewise Therapeutics, For: Jul 01 Filed by: Russell Alan J
View All Articles

Entities mentioned with EWTX

View All Entities